FDA approves Akynzeo for nausea and vomiting

01 Nov 2014 11:30 AM | Lori Aubrey (Administrator)

The U.S. Food and Drug Administration approved Akynzeo (netupitant and palonosetron) to treat nausea and vomiting in patients undergoing cancer chemotherapy.

FDA Approvals


Comments

Northern New England Clinical Oncology Society
P.O. Box 643
Sandown, NH 03873-0643
Telephone (603) 887-1948
info@nnecos.org

This website brought to you by:


Powered by Wild Apricot Membership Software